Effects of interleukin-1β and tumor necrosis factor-α on expression of matrix-related genes by cultured equine articular chondrocytes

American Journal of Veterinary Research

Volumn 61, Issue 6, 2000, Pages 624-630

  Richardson, Dean W ^a   Dodge, George R ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE;

COLLAGENASE; COLLAGENASE 3; GLYCOSAMINOGLYCAN; INTERLEUKIN 1; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MMP13 PROTEIN, HUMAN; STROMELYSIN; SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL DISEASE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CHEMISTRY; CYTOLOGY; FLUOROMETRY; GENE EXPRESSION REGULATION; GENETICS; HORSE; IMAGE PROCESSING; METABOLISM; NONPARAMETRIC TEST; NORTHERN BLOTTING; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SCINTILLATION COUNTING; WESTERN BLOTTING;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CHONDROCYTES; COLLAGENASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUOROMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOSAMINOGLYCANS; HORSES; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES; SCINTILLATION COUNTING; STATISTICS, NONPARAMETRIC; SULFATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034199851     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.624     Document Type: Article

References (50)

1. Richardson D, Dodge G. Cloning of equine type II procollagen and the modulation of its expression in cultured equine articular chondrocytes. Matrix Biol 1997;16:59-64.
2. Todhunter RJ, Wootton JAM, Lust G, et al. Structure of equine type I and type II collagens. Am J Vet Res 1994;55:425-431.
3. Hardingham TE, Fosang AJ, Dudhia J. The structure, function and turnover of aggrecan, the large aggregating proteoglycan from cartilage. Eur J Clin Chem Clin Biochem 1994;32:249-257.
4. Bonnet F, Dunham DG, Hardingham TE. Structure and interactions of cartilage proteoglycan binding region and link protein. Biochem J 1985;228:77-85.
5. Dudhia J, Platt D. Complete primary sequence of equine cartilage link protein deduced from complementary DNA. Am J Vet Res 1995;56:959-965.
6. Roughley PJ, Lee ER. Cartilage proteoglycans: structure and potential functions. Microsc Res Tech 1994;28:385-397.
7. Little CB, Ghosh P, Rose R. The effect of strenuous versus moderate exercise on the metabolism of proteoglycans in articular cartilage from different weight-bearing regions of the equine third carpal bone. Osteoarthritis Cartilage 1997;5:161-172.
8. Roughley PJ, Melching LI, Recklies AD. Changes in the expression of decorin and biglycan in human articular cartilage with age and regulation by TGF-beta. Matrix Biol 1994;14:51-59.
9. Pelletier JP, Roughley PJ, DiBattista JA, et al. Are cytokines involved in osteoarthritic pathophysiology? Semin Arthritis Rheum 1991;20:12-25.
10. Shinmei M, Masuda K, Kikuchi T, et al. Production of cytokines by chondrocytes and its role in proteoglycan degradation. J Rheumatol 1991;27(suppl):89-91.
11. MacNaul KL, Chartrain N, Lark M, et al. Differential effects of IL-1 and TNF alpha on the expression of stromelysin, collagenase and their natural inhibitor, TIMP, in rheumatoid human synovial fibroblasts. Matrix Suppl 1992;1:198-199.
12. Miller VE, Rogers K, Muirden KD. Detection of tumour necrosis factor alpha and interleukin-1 beta in the rheumatoid osteoarthritic cartilage-pannus junction by immunohistochemical methods. Rheumatol Int 1993;13:77-82.
13. Morris EA, Treadwell BV. Effect of interleukin 1 on articular cartilage from young and aged horses and comparison with metabolism of osteoarthritic cartilage. Am J Vet Res 1994;55: 138-146.
14. MacDonald MH, Stover SM, Willits NH, et al. Regulation of matrix metabolism in equine cartilage explant cultures by interleukin 1. Am J Vet Res 1992;53:2278-2285.
15. May SA, Hooke RE, Lees P. Interleukin-1 stimulation of equine articular cells. Res Vet Sci 1992;52:342-348.
16. Caron JP, Tardif G, Martel-Pelletier J, et al. Modulation of matrix metalloprotease 13 (collagenase 3) gene expression in equine chondrocytes by interleukin 1 and corticosteroids. Am J Vet Res 1996;57:1631-1634.
17. Billinghurst RC, Fretz PB, Gordon JR. Induction of intraarticular tumour necrosis factor during acute inflammatory responses in equine arthritis. Equine Vet J 1995;27:208-216.
18. 2 values in horses. Am J Vet Res 1993;54:379-386.
19. Glade MJ, Kanwar YS, Hefley TJ. Enzymatic isolation of chondrocytes from immature rabbit articular cartilage and maintenance of phenotypic expression in culture. J Bone Miner Res 1991;6:217-226.
20. Reginato AM, Iozzo RV, Jimenez SA. Formation of nodular structures resembling mature articular cartilage in long-term primary cultures of human fetal epiphyseal chondrocytes on a hydrogel substrate. Arthritis Rheum 1994;37:1338-1349.
21. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883:173-177.
22. Clegg PD, Burke RM, Coughlan AR, et al. Characterisation of equine matrix metalloproteinase 2 and 9: and identification of the cellular sources of these enzymes in joints. Equine Vet J 1997;29:335-342.
23. Chandrasekhar S, Phadke K. Interleukin-1-induced alterations in proteoglycan metabolism and matrix assembly. Arch Biochem Biophys 1988;265:294-301.
24. Tang LH, Buckwalter JA, Rosenberg LC. Effect of link protein concentration on articular cartilage proteoglycan aggregation. J Orthop Res 1996;14:334-339.
25. Bolton MC, Dudhia J, Bayliss MT. Quantification of aggrecan and link-protein mRNA in human articular cartilage of different ages by competitive reverse transcriptase-PCR. Biochem J 1996;319:489-498.
26. von den Hoff H, de Koning M, van Kampen J, et al. Interleukin-1 reversibly inhibits the synthesis of biglycan and decorin in intact articular cartilage in culture. J Rheumatol 1995;22:1520-1526.
27. Qwarnstrom EE, Jarvelainen HT, Kinsella MG, et al. Interleukin-1 beta regulation of fibroblast proteoglycan synthesis involves a decrease in versican steady-state mRNA levels. Biochem J 1993;294:613-620.
28. Demoor-Fossard M, Redini F, Boittin M, et al. Expression of decorin and biglycan by rabbit articular chondrocytes. Effects of cytokines and phenotypic modulation. Biochim Biophys Acta 1998;1398:179-191.
29. Visser NA, Vankampen GP, Dekoning MH, et al. The effects of loading on the synthesis of biglycan and decorin in intact mature articular cartilage in vitro. Connect Tissue Res 1994;30:241-250.
30. Little CB, Ghosh P, Bellenger CR. Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: an experimental study in sheep. J Orthop Res 1996;14:433-444.
31. Visser NA, de Koning MH, Lammi MJ, et al. Increase of decorin content in articular cartilage following running. Connect Tissue Res 1998;37:295-302.
32. Masse PG, Carrino DA, Morris N, et al. Loss of decorin from the surface zone of articular cartilage in a chick model of osteoarthritis. Acta Histochemica 1997;99:431-444.
33. Kuc IM, Scott PG. Increased diameters of collagen fibrils precipitated in vitro in the presence of decorin from various connective tissues. Connect Tissue Res 1997;36:287-296.
34. Hagg R, Bruckner P, Hedbom E. Cartilage fibrils of mammals are biochemically heterogeneous: differential distribution of decorin and collagen IX. J Cell Biol 1998;142:285-294.
35. Mizoguchi I, Scott PG, Dodd CM, et al. An immunohistochemical study of the localization of biglycan, decorin and large chondroitin-sulphate proteoglycan in adult rat temporomandibular joint disc. Arch Oral Biol 1998;43:889-898.
36. Roughley PJ, Rodriguez E, Lee ER. The interactions of 'non-aggregating' proteoglycans. Osteoarthritis Cartilage 1995;3:239-248.
37. Schonherr E, Witsch-Prehm P, Harrach B, et al. Interaction of biglycan with type I collagen. J Biol Chem 1995;270:2776-2783.
38. Ramasamy S, Lipke DW, McClain CJ, et al. Tumor necrosis factor reduces proceoglycan synthesis in cultured endothelial cells. J Cell Physiol 1995;162:119-126.
39. Noyori K, Takagi T, Jasin HE. Characterization of the macromolecular components of the articular cartilage surface. Rheumatol Int 1998;18:71-77.
40. Knauper V, Lopez-Otin C, Smith B, et al. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544-550.
41. Reboul P, Pelletier JP, Tardif G, et al. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 1996;97:2011-2019.
42. Stahle-Backdahl M, Sandstedt B, Bruce K, et al. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 1997;76:717-728.
43. Billinghurst RC, Dahlberg L, Ionescu M, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-1545.
44. Lohmander LS, Neame PJ, Sandy JD. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum 1993;36: 1214-1222.
45. Lark MW, Bayne EK, Flanagan J, et al. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 1997;100:93-106.
46. Arner EC, Pratta MA, Trzaskos JM, et al. Generation and characterization of aggrecanase. A soluble, cartilage-derived aggrecan-degrading activity. J Biol Chem 1999;274:6594-6601.
47. Tortorella MD, Burn TC, Pratta MA, et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999;284:1664-1666.
48. Arner EC, Dimeo TM, Pratta MA, et al. Interleukin-1 induces aggrecanase-mediated cleavage in human articular cartilage without up-regulating stromelysin or glycosaminoglycan release. Acta Orthop Scand 1995;66:153-154.
49. Buttle DJ, Fowles A, Ilic MZ, et al. "Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay. Mol Pathol 1997;50:153-159.
50. Clegg PD, Coughlan AR, Riggs CM, et al. Matrix metalloproteinases 2 and 9 in equine synovial fluids. Equine Vet J 1997;29:343-348.